section name header

Y-Site Injection Compatibility (1:1 Mixture)

Doxorubicin HCl liposomal

(Mfr: SEQ)(Conc: 0.4 mg/mLa)

I

Metoclopramide HCl

(Mfr: GNS)(Conc: 5 mg/mL)

Remarks:

Increase in measured turbidity

Ref:

2087